TR201203341A2 - Ranolazin sürekli salım tableti. - Google Patents

Ranolazin sürekli salım tableti.

Info

Publication number
TR201203341A2
TR201203341A2 TR2012/03341A TR201203341A TR201203341A2 TR 201203341 A2 TR201203341 A2 TR 201203341A2 TR 2012/03341 A TR2012/03341 A TR 2012/03341A TR 201203341 A TR201203341 A TR 201203341A TR 201203341 A2 TR201203341 A2 TR 201203341A2
Authority
TR
Turkey
Prior art keywords
sustained release
release tablet
ranolazine sustained
ranolazine
ranolase
Prior art date
Application number
TR2012/03341A
Other languages
English (en)
Inventor
Ölçer Muharrem
Original Assignee
Helba İlaç İç Ve Diş San. Ti̇c. Ltd. Şti̇
Ölçer Muharrem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helba İlaç İç Ve Diş San. Ti̇c. Ltd. Şti̇, Ölçer Muharrem filed Critical Helba İlaç İç Ve Diş San. Ti̇c. Ltd. Şti̇
Priority to TR2012/03341A priority Critical patent/TR201203341A2/tr
Publication of TR201203341A2 publication Critical patent/TR201203341A2/tr

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Ranolazın içeren sürekli salım tableti ile ilgilidir. Salım kontrol ajam olarak hıdroksıpropil metilselüloz asetat suksinat ve yağ asidi esten veya alkolü içerir.
TR2012/03341A 2012-03-23 2012-03-23 Ranolazin sürekli salım tableti. TR201203341A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2012/03341A TR201203341A2 (tr) 2012-03-23 2012-03-23 Ranolazin sürekli salım tableti.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2012/03341A TR201203341A2 (tr) 2012-03-23 2012-03-23 Ranolazin sürekli salım tableti.

Publications (1)

Publication Number Publication Date
TR201203341A2 true TR201203341A2 (tr) 2012-12-21

Family

ID=47679792

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2012/03341A TR201203341A2 (tr) 2012-03-23 2012-03-23 Ranolazin sürekli salım tableti.

Country Status (1)

Country Link
TR (1) TR201203341A2 (tr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017001669A1 (en) 2015-07-02 2017-01-05 Interquim, S.A. Ranolazine multiple compressed tablets
WO2018001582A1 (en) 2016-06-30 2018-01-04 Interquim, S.A. Ranolazine multiple compressed tablets

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017001669A1 (en) 2015-07-02 2017-01-05 Interquim, S.A. Ranolazine multiple compressed tablets
WO2018001582A1 (en) 2016-06-30 2018-01-04 Interquim, S.A. Ranolazine multiple compressed tablets

Similar Documents

Publication Publication Date Title
TWD163742S (zh) 顯示螢幕的圖像
TWD163744S (zh) 顯示螢幕的圖像
EP3088429A4 (en) Modified polyvinyl alcohol and water-soluble film containing same
IN2015MN00020A (tr)
AR096975A1 (es) Formulación líquida en aerosol de un artículo electrónico para fumar
CL2014001930A1 (es) Formulacion farmacéutica que comprende un anticuerpo angiopoyetina 2 (anti-ang2).
BR112015021410A2 (pt) inibidores macrocíclicos das interações das proteína/proteína pd-1/pd-l1 e cd80(b7-1)/pd-l1
HUE049076T2 (hu) Módosított polivinil-akohol, és az azt tartalmazó vízoldható film
TWD163749S (zh) 顯示螢幕的圖像
TWD164803S (zh) 顯示螢幕之圖像
TWD158424S (zh) 音訊揚聲器系統之部分
MX2020003096A (es) Formulaciones farmaceuticas de un inhibidor de hidroxilasa de hif.
EP3060681A4 (en) Genetic markers predictive of response to glatiramer acetate
AU345217S (en) Fire detector
TWD156928S (zh) 化妝品展示台
TWD163743S (zh) 顯示螢幕的圖像
UY34786A (es) Procedimiento para la fabricación de una forma farmacéutica que comprende nifedipino y candesartan cilexetilo
BR112015014853A2 (pt) Formulação farmacêutica, formulação farmacêutica liofilizada, uso de uma formulação farmacêutica e artigo de manufatura
UY34842A (es) Formulaciones estabilizadas que contienen anticuerpos anti-dll4
TWD163738S (zh) 顯示螢幕之圖像
AR093402A1 (es) Producto de comicronizacion que comprende acetato de ulipristal
EP3011061A4 (en) VIRION DISPLAY MATRIX FOR PROFILING THE FUNCTIONS AND INTERACTIONS OF HUMAN MEMBRANE PROTEINS
BR112013010709A2 (pt) derivado de ácido trans-2-decenoico e agente farmacêutico contendo o mesmo
TWD163740S (zh) 顯示螢幕的圖像
EA201591787A1 (ru) Таблетки совапревира